51 related articles for article (PubMed ID: 26230976)
1. Early Stage Triple-Negative Breast Cancer: Imaging and Clinical-Pathologic Factors Associated with Recurrence.
Bae MS; Moon HG; Han W; Noh DY; Ryu HS; Park IA; Chang JM; Cho N; Moon WK
Radiology; 2016 Feb; 278(2):356-64. PubMed ID: 26230976
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced breast magnetic resonance imaging for the prediction of early and late recurrences in breast cancer.
Choi EJ; Choi H; Choi SA; Youk JH
Medicine (Baltimore); 2016 Nov; 95(48):e5330. PubMed ID: 27902592
[TBL] [Abstract][Full Text] [Related]
3. Low breast density and peritumoral edema on MR predict worse overall survival of breast cancer patients after neoadjuvant chemotherapy.
Yang Z; Wang N; Han R; Tang Y; Chen H; Xie Y; Wang R; Tang L
Eur J Radiol; 2024 Feb; 171():111294. PubMed ID: 38218065
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer distant recurrence lead time interval by detection method in an institutional cohort.
Kaplan HG; Malmgren JA; Atwood MK
BMC Cancer; 2020 Nov; 20(1):1124. PubMed ID: 33218313
[TBL] [Abstract][Full Text] [Related]
5. Incidence and Predictors of Recurrence among Breast Cancer Patients in Black Lion Specialized Hospital Adult Oncology Unit, Addis Ababa, Ethiopia: Retrospective Follow-up Study with Survival Analysis.
Shiferaw WS; Aynalem YA; Akalu TY; Demelew TM
J Cancer Prev; 2020 Jun; 25(2):111-118. PubMed ID: 32647652
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Implication of Focal Breast Edema on Preoperative Breast Magnetic Resonance Imaging in Breast Cancer Patients.
Sung P; Lee JY; Cheun JH; Choi IS; Park JH; Park JH; Kim BH; Oh S; Chu AJ; Hwang KT
J Breast Cancer; 2023 Oct; 26(5):479-491. PubMed ID: 37704381
[TBL] [Abstract][Full Text] [Related]
7. Age of 40 years or younger is an independent risk factor for locoregional failure in early breast cancer: a single-institutional analysis in saudi arabia.
Rudat V; El-Sweilmeen H; Fadel E; Brune-Erber I; Ahmad Nour A; Bushnag Z; Masri N; Altuwaijri S
J Oncol; 2012; 2012():370385. PubMed ID: 22545048
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of the intrinsic molecular subtypes of breast cancer.
Prat A; Pineda E; Adamo B; Galván P; Fernández A; Gaba L; Díez M; Viladot M; Arance A; Muñoz M
Breast; 2015 Nov; 24 Suppl 2():S26-35. PubMed ID: 26253814
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal Women.
Fabian CJ; Kimler BF; Phillips TA; Nydegger JL; Kreutzjans AL; Carlson SE; Hidaka BH; Metheny T; Zalles CM; Mills GB; Powers KR; Sullivan DK; Petroff BK; Hensing WL; Fridley BL; Hursting SD
Cancer Prev Res (Phila); 2015 Oct; 8(10):922-31. PubMed ID: 26276744
[TBL] [Abstract][Full Text] [Related]
10. Impact of preventive therapy on the risk of breast cancer among women with benign breast disease.
Cuzick J; Sestak I; Thorat MA
Breast; 2015 Nov; 24 Suppl 2(Suppl 2):S51-5. PubMed ID: 26255741
[TBL] [Abstract][Full Text] [Related]
11. An overview of triple-negative breast cancer.
Kumar P; Aggarwal R
Arch Gynecol Obstet; 2016 Feb; 293(2):247-69. PubMed ID: 26341644
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer tumour growth modelling for studying the association of body size with tumour growth rate and symptomatic detection using case-control data.
Abrahamsson L; Czene K; Hall P; Humphreys K
Breast Cancer Res; 2015 Aug; 17():116. PubMed ID: 26293658
[TBL] [Abstract][Full Text] [Related]
13. Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic Density.
Wu AH; Spicer D; Garcia A; Tseng CC; Hovanessian-Larsen L; Sheth P; Martin SE; Hawes D; Russell C; MacDonald H; Tripathy D; Su MY; Ursin G; Pike MC
Cancer Prev Res (Phila); 2015 Oct; 8(10):942-51. PubMed ID: 26276750
[TBL] [Abstract][Full Text] [Related]
14. Differences in Molecular Subtype Reference Standards Impact AI-based Breast Cancer Classification with Dynamic Contrast-enhanced MRI.
Ji Y; Whitney HM; Li H; Liu P; Giger ML; Zhang X
Radiology; 2023 Apr; 307(1):e220984. PubMed ID: 36594836
[TBL] [Abstract][Full Text] [Related]
15. Correlation of dynamic contrast-enhanced MRI and diffusion-weighted MR imaging with prognostic factors and subtypes of breast cancers.
Chen H; Li W; Wan C; Zhang J
Front Oncol; 2022; 12():942943. PubMed ID: 35992872
[TBL] [Abstract][Full Text] [Related]
16. Radiologic-pathologic correlation in breast cancer: do MRI biomarkers correlate with pathologic features and molecular subtypes?
Galati F; Rizzo V; Moffa G; Caramanico C; Kripa E; Cerbelli B; D'Amati G; Pediconi F
Eur Radiol Exp; 2022 Aug; 6(1):39. PubMed ID: 35934721
[TBL] [Abstract][Full Text] [Related]
17. Contralateral Breast Screening with Preoperative MRI: Long-Term Outcomes for Newly Diagnosed Breast Cancer.
Freitas V; Li X; Amitai Y; Au F; Kulkarni S; Ghai S; Mulligan AM; Bromley M; Siepmann T
Radiology; 2022 Aug; 304(2):297-307. PubMed ID: 35471109
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC).
Abdelhafez AH; Musall BC; Adrada BE; Hess K; Son JB; Hwang KP; Candelaria RP; Santiago L; Whitman GJ; Le-Petross HT; Moseley TW; Arribas E; Lane DL; Scoggins ME; Leung JWT; Mahmoud HS; White JB; Ravenberg EE; Litton JK; Valero V; Wei P; Thompson AM; Moulder SL; Pagel MD; Ma J; Yang WT; Rauch GM
Breast Cancer Res Treat; 2021 Jan; 185(1):1-12. PubMed ID: 32920733
[TBL] [Abstract][Full Text] [Related]
19. Breast MRI: State of the Art.
Mann RM; Cho N; Moy L
Radiology; 2019 Sep; 292(3):520-536. PubMed ID: 31361209
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Molecular Biomarkers in Breast Cancer Lesions with Non-Mass Enhancement on MR.
Wang ML; Chang YP; Wu CH; Chen CH; Gueng MK; Wu YY; Chai JW
Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
